Removing zelnecirnon means the biotech’s sole remaining clinical-stage asset is tivumecirnon, a phase 2 oncology med being ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

A CRL is issued by the FDA when it deems that the regulatory application is not complete in its current form. The deficiencies usually that lead to rejection could be the need for additional ...

Yes, you may be responding to current news items, but so are many other traders. Understand your limitations before jumping into a trade that may or may not be timely or make sense. Premarket ...

One of the fun parts of the ESP32-S3 microcontroller is that it got upgraded to the newer Cadence Xtensa LX7 processor core, which turns out to have a range of SIMD instructions that can help to ...

The Food and Drug Administration is making it easier for people to simultaneously test themselves for COVID-19 and the flu at home. The agency this week authorized the Healgen Scientific's Rapid ...

By Katherine Schulten Weekly Student News Quiz: Election Day, World Series, Floods Have you been paying attention to current events recently? See how many of these 10 questions you can get right.

Fox News has the latest uplifting videos, photos and stories from Americans revealing their most special moments sure to tug at your heartstrings.

Davis, MD, chief medical officer of Neuvivo, told Fox News Digital. There are currently no FDA-approved treatments ... confirmed that current ALS treatments are "very limited" in their effectiveness.